September, 2025
September 2025
M T W T F S S
1234567
891011121314
15161718192021
22232425262728
2930  
Oncology Updates: August Edition from BG Lab
Sep 3, 2025, 07:55

Oncology Updates: August Edition from BG Lab

BG Lab shared a post on X:

“We (BG Lab) had a very productive August. Please tag along for an update on the major accomplishments from our team in August.

Our visiting colleague Laure-Anne Teuwen published an editorial in JNCI about clinical versus statistical significance.

Title: Success in oncology phase 3 trials: a small P value or patient value

Authors: Laure-Anne Teuwen, Gregory R Pond, Bishal Gyawali

Read the Full Article.

BG Lab

Our Common Sense Oncology fellow Samuel Stevens published a commentary in ACS Journal Cancer  highlighting the need for precision in dosing, endpoints and trial reporting in the context of codebreak 300 trial.

Title: CodeBreaK or code blue? Assessing sotorasib’s vital signs in metastatic colorectal cancer

Authors: Samuel X. Stevens, M Bioethics, Bishal Gyawali

Read the Full Article.

BG Lab

Our visiting colleague Laure-Anne Teuwen published another editorial in BMJ Oncology discussing the control arms in clinical trials run in LMICs.

Title: Inferior control arms in oncology trials in LMICs: contextualised or compromised?

Authors: Laure-Anne Teuwen, Bishal Gyawali

Read the Full Article.

BG Lab

Our team leader Bishal Gyawali discussed the intersection of CSO and precision oncology in this piece published in Marathon of Hope Cancer Centres Network.

Oncology Updates: August Edition from BG Lab

More posts featuring Bishal Gyawali on OncoDaily.